Profile: Xillix Technologies Corp. is a medical device company focused on research, development and commercialization of fluorescence endoscopy for the improved detection and localization of cancer. Our core light induced fluorescence endoscopy helps physicians diagnose early-stage lung and gastrointestinal cancers. Our technologies include Xillix LIFE, LIFE-Lung and LIFE-GI. Our Xillix LIFE, LIFE-Lung and LIFE-GI are fluorescence endoscopy systems for lung, gastro-intestinal track and ear, nose & throat (ENT).

The company has revenues of < USD 1 Million, has ~40 employees. TSE:XLX (SEC Filings)